J2469 HCPCS Level II code: Injection, palonosetron hcl, 25 mcg
J2469 is the HCPCS code for “Injection, palonosetron hcl, 25 mcg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2469Injection, palonosetron hcl, 25 mcg
Short description: Palonosetron hcl
HCPCS · United States
Medicare details
The indicators CMS publishes with J2469 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2005
Where J2469 sits
- 1J codesDrugs administered other than orally
- 2Active code J2469Injection, palonosetron hcl, 25 mcg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2469 mean?
J2469 is the HCPCS code for “Injection, palonosetron hcl, 25 mcg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2469?
CMS lists J2469’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2469
All J codesJ2427Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mgJ2428Injection, paliperidone palmitate extended release (erzofri), 1 mgJ2430Injection, pamidronate disodium, per 30 mgJ2440Injection, papaverine hcl, up to 60 mgJ2460Injection, oxytetracycline hcl, up to 50 mgJ2468Injection, palonosetron hydrochloride (posfrea), 25 microgramsJ2470Injection, pantoprazole sodium, 40 mgJ2471Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mgJ2472Injection, pantoprazole sodium in sodium chloride (baxter), 40 mgJ2501Injection, paricalcitol, 1 mcgJ2502Injection, pasireotide long acting, 1 mgJ2503Injection, pegaptanib sodium, 0.3 mg